Immunogenicity 468
Sample ID
None
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ENDOV
Transcript ID
None
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (264 aa)
MALEA
1
AGGPP
6
EETLS
11
LWKRE
16
QARLK
21
AHVVD
26
RDTEA
31
WQRDP
36
AFSGL
41
QRVGG
46
VDVSF
51
VKGDS
56
VRACA
61
SLVVL
66
SFPEL
71
EVLLV
76
DGNGV
81
LHHRG
86
FGVAC
91
HLGVL
96
TDLPC
101
VGVAK
106
KLLQV
111
DGLEN
116
NALHK
121
EKIRL
126
LQTRG
131
DSFPL
136
LGDSG
141
TVLGM
146
ALRSH
151
DRSTR
156
PLYIS
161
VGHRM
166
SLEAA
171
VRLTC
176
CCCRF
181
RIPEP
186
VRQAD
191
ICSRE
196
HIRKS
201
LGLPG
206
PPTPR
211
SPKAQ
216
RPVAC
221
PKGDS
226
GESSG
231
EGQPP
236
QDHSP
241
GPRTA
246
PRPGS
251
QEQAG
256
KDWQ
261
Mutation Information
DNA mutation:
None
Peptide Range:
248 ~ 268
Mut AA position:
257 (10 in Wild Type peptide)
Alignment
Wild Type:
"----RTAPRPGSQE-------
|||||||||.
Mutant:
SPGPRTAPRPGSQKQAGKDWQ"
Nature, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaGene Name (from Reference) ENDOV
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
autologous APCs
Assay
IFNg ELISPOT assay